万维提示：
1、投稿方式：在线投稿。
2、期刊网址：
https://onlinelibrary.wiley.com/journal/14422042
3、投稿网址：https://mc.manuscriptcentral.com/iju
4、官网邮箱：IJUEO@wiley.com（编辑部）
5、官网电话：81 3 3830 1268
6、期刊刊期：月刊，一年出版12期。
2021年8月4日星期三
投稿须知【官网信息】
International Journal of Urology
AUTHOR GUIDELINES
Please take a moment to consult the following instructions to help you prepare your manuscript, and feel free to contact us with any questions. To ensure fast peer review and publication, manuscripts that do not adhere to the following instructions will be returned to the corresponding author for technical revision before undergoing peer review.
Please download the Author Submission Requirement Form from here. This form can be uploaded with the manuscript at ScholarOne Manuscript.
1. ABOUT THE JOURNAL
Scope: IJU is the official English journal of The Japanese Urological Association and Urological Association of Asia. It publishes original research articles dealing with clinical and laboratory urology.
Editor: Hideaki Miyake
Frequency: Monthly
ISSN: 1442-2042 (online)
Journal abbreviation: Int J Urol
Publisher: Wiley, an imprint of John Wiley & Sons, Inc.
Once the submission materials have been prepared in accordance with the Author Guidelines, manuscripts should be submitted online at https://mc.manuscriptcentral.com/iju
For help with submissions, please contact:
Editorial Office
International Journal of Urology
c/o Wiley
Koishikawa Sakura Bldg 4F,
1-28-1 Koishikawa, Bunkyo-ku,
Tokyo 112-0002, Japan
Email: IJUEO@wiley.com
Tel: 81 3 3830 1268
Fax: 81 3 5689 7278
This journal does not charge submission fees.
2. EDITORIAL REVIEW AND ACCEPTANCE
The acceptance criteria for all papers are the quality and originality of the research and its significance to our readership. Except where otherwise stated, manuscripts are single-blind peer reviewed by two or more anonymous reviewers and the Editor. The Editorial Board reserves the right to refuse any material for publication and advises that authors should retain copies of submitted manuscripts and correspondence as material cannot be returned. Final acceptance or rejection rests with the Editorial Board.
All manuscripts should be written so that they are intelligible to the professional reader who is not a specialist in the particular field. They should be written in a clear, concise, direct style. Where contributions are judged as acceptable for publication on the basis of urologic content, the Editor and the Publisher reserve the right to modify manuscripts to eliminate ambiguity and repetition and improve communication between author and reader. If extensive alterations are required, the manuscript will be returned to the author for revision. Authorship must be finalized during the submission process. Please ensure that all authors are listed and in the correct order, because changes are not permissible once the accepted manuscript goes into production.
In-house submissions, i.e. papers authored by Editors or Editorial Board members of the title, will be sent to Editors unaffiliated with the author or institution and monitored carefully to ensure there is no peer review bias.
This journal participates in Wiley’s Transfer Desk Assistant program
3. SUBMISSION
ARTICLE PREPARATION SUPPORT
Wiley Editing Services offers expert help with English Language Editing, as well as translation, manuscript formatting, figure illustration, figure formatting, and graphical abstract design – so you can submit your manuscript with confidence.
Also, check out our resources for Preparing Your Article for general guidance about writing and preparing your manuscript.
PREPRINT POLICY
This journal will consider for review articles previously available as preprints. Authors may also post the submitted version of a manuscript to a preprint server at any time. Authors are requested to update any pre-publication versions with a link to the final published article.
DATA SHARING AND DATA AVAILABILITY
IJU encourages authors to share the data and other artefacts supporting the results in the paper by archiving it in an appropriate public repository. Authors should include a data accessibility statement, including a link to the repository they have used, in order that this statement can be published alongside their paper.
AUTHORSHIP
IJU follows the recommendations formulated by the International Committee of Medical Journal Editors regarding criteria for authorship. Accordingly, each person listed as an author or co-author for a submitted manuscript must meet all four criteria. An author or co-author shall have:
1) Substantial contributions to the conception or design of the work, or acquisition, analysis or interpretation of data for the work;
2) Drafting the work or revising it critically for important intellectual content;
3) Final approval of the version to be published;
4) Agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved. Meeting these criteria should provide each author with sufficient knowledge of and participation in the work that he or she can accept public responsibility for the report.
Person who does not meet the above 4 criteria should be mentioned in the acknowledgment section.
ORCiD
As part of our commitment to supporting authors at every step of the publishing process, the journal requires the submitting author (only) to provide an ORCID iD when submitting a manuscript. This takes around 2 minutes to complete. Find more information.
ARTICLE TYPES
(1) ORIGINAL ARTICLE
Word limit: 3,000 words including abstract but excluding references, tables and figures.
Abstract: 250 words maximum, structured (subheaders): Objectives, Methods, Results, Conclusions.
References: Up to 30 in total.
Description: Full-length reports of current research in either basic or clinical science. Arrange text as follows: Introduction, Methods, Results, Discussion, Acknowledgment, Disclosure, References, and when relevant, Supplementary Material.
(2) REVIEW ARTICLE [BY INVITATION OF EDITORS]
Word limit: from 2,500 to 5,000 words including abstract but excluding references, tables and figures.
Abstract: 250 words maximum, structured or unstructured.
References: No limit.
Figures/tables: Minimum 3 tables, images or figures in total.
Description: Reviews are comprehensive analyses of specific topics. They are submitted upon invitation by the Editor. Proposals for reviews may be submitted; however, in this case authors should only send an outline of the proposed paper for initial consideration. Both solicited and unsolicited review articles will undergo peer review prior to acceptance.
(3) UROLOGICAL NOTE
Word limit: 700 words excluding references, figure/table legend.
Authors: Maximum six authors.
Abstract: No abstract.
References: Up to 7 in total.
Figures/tables: Up to 1 (multi panel figures allowed). Additional tables/figures should be submitted as supporting Information.
Description: Urological Notes are concise reports; in particular, techniques used to overcome problems, skills, or problems to be aware of which can be of great interest to the clinician. Also accepted are papers which present new findings derived from a small data set, or new findings that will substantially and immediately affect research or clinical practice. Urological Notes should not include a detailed report or discussion, but mini reviews are acceptable. Text should be unstructured, and subheadings should not be used.
(4) LETTER TO THE EDITOR
Word limit: 500 words.
Authors: Maximum three authors.
Abstract: No abstract.
References: Up to 4 in total.
Figures/tables: Up to 1 (multi panel figures allowed).
Description: Letters commenting on recently published papers in IJU can be submitted to the Editor and they may be subjected to peer-review. Submissions may be edited for length, grammatical correctness, and journal style. Authors will be asked to approve editorial changes that alter the substance or tone of a letter or response. Letters that offer perspective on content already published in IJU can use an arbitrary title, but a response from authors must cite the title of the first letter: e.g. Response to [title of Letter]. This ensures that readers can track the line of discussion.
(5) PERSPECTIVE [BY INVITATION OF EDITORS]
Word limit: 500 words.
Abstract: No abstract.
References: Up to 10 in total.
Figures/tables: Up to 2 (multi panel figures allowed).
Description: Scientific views including opinions which may oppose to the general and standard ones yet have potentiality to open up a new view. There is no specific format for this article type. Video clips may be submitted as supporting information.
(6) EDITORIAL COMMENTS [BY INVITATION OF EDITORS]
Word limit: 550 words including references.
References: Up to 5 in total.
(7) EDITORIAL [BY INVITATION OF EDITORS]
Word limit: 1,600 words.
Abstract: No abstract.
References: Up to 5 in total.
Description: Proposals for Editorials may be submitted; however, in this case authors should only send an outline of the proposed paper for initial consideration.
(8) GUIDELINES
[If you wish to submit Guidelines to IJU, please contact the IJU Editorial Office (IJUEO@wiley.com) before submission. Final acceptance or rejection of the Guidelines will rest with the Editorial Board]
Word limit: Consulting with editor.
Abstract: 250 words, unstructured (no use of subheaders).
References: All references must be collated at the end of the text.
Description: Statements designed to help clinicians make decisions about appropriate diagnosis and treatment for specific circumstances.
(9) MEETING REPORT/ABSTRACT [BY INVITATION OF EDITORS]
Word limit: To be determined in consultation with Editors.
Preface: 250 words, unstructured (no use of subheaders).
References: No limit.
Description: These are authoritative proceedings of specific topics in urology that are usually solicited by the Editors. Proposals for these articles may be submitted; however, in this case authors should only send an outline of the proposed paper for initial consideration. Both solicited and unsolicited articles will undergo peer review prior to acceptance.
ETHICAL CONSIDERATION
Conflict of Interest
Authors must declare any financial support or relationships that may pose a conflict of interest by disclosing at the time of submission any financial arrangements they have with a company whose product figures prominently in the submitted manuscript or with a company making a competing product. The corresponding author should collect all authors COI disclosure form and must submit it before publication of the manuscript.
A Conflict of Interest statement needs to be supplied and will be included as part of the published paper after the Disclosure of Ethical Statement section and before the reference (examples are given below).
Author A.Y. (by Name) was supported by grants or donations from xxx etc., author A. Y has a leadership role in a private company, author B.Y and C.Y owns stock of xxx etc., and author D.Y has a patent for xxx. (If you have other potential Conflict of Interests, please list here by name) Author E.Y received devices from xxx. The funding for this study was provided by xxx. (When the funding source had no role in the design, practice or analysis of this study, please put the next sentence here): The funding source had no role in the design, practice or analysis of this study.
OR
The absence of any interest to disclose must also be stated as "The authors declare no conflict of interest."
Human Studies
Authors must state that the protocol for the research project has been approved by a suitably constituted Ethics Committee of the institution within which the work was undertaken and that it conforms to the provisions of the Declaration of Helsinki (as revised in Fortaleza, Brazil, October 2013), available at: https://www.wma.net/what-we-do/education/.
In general, submission of a study in which case are represented should be accompanied by the written consent of the subject (or parent/guardian) before publication; this is particularly important where photographs are to be used or in cases where the unique nature of the incident reported makes it possible for the patient to be identified. While the Editors recognize that it might not always be possible or appropriate to seek such consent, the onus will be on the authors to demonstrate that this exception applies in their case. The authors must state about the full name and the institution of the review committee with the approval number in the Disclosure section of their manuscript using the following phrases:
The protocol for this research project has been approved by a suitably constituted Ethics Committee of the institution and it conforms to the provisions of the Declaration of Helsinki. Committee of xxxx, Approval No. xxxx. (If cases are involved) All informed consent was obtained from the subject(s) and/or guardian(s)
Animal Studies
Any experiments involving animals must be demonstrated to be ethically acceptable and where relevant conform to national guidelines for animal usage in research , as well as specific national laws (e.g. the current version of the German Law on the Protection of Animals) where applicable. The author must state the above in the disclosure section using the following phrases:
All animal experiments were conducted following the national guidelines and the relevant national laws on the protection of animals.
IJU retains the right to reject any manuscript on the basis of unethical conduct of either human or animal studies.
……
更多详情：
https://onlinelibrary.wiley.com/page/journal/14422042/homepage/forauthors.html
